New hires:
VC firm Canaan Partners brought in Uwe Schoenbeck, PhD, to its healthcare investment team as a new Venture Partner. Schoenbeck formerly served as SVP and chief scientific officer of emerging science and innovation in Pfizer‘s worldwide research, development and medical division.
Domain Therapeutics named Sean A. MacDonald as CEO.
FundaMental Pharma appointed Dr. Dirk Beher as CEO.
Endeavor BioMedicines added Chris Krueger, JD as chief operating officer.
Clinical-stage biotech Recursion appointed Najat Khan, PhD as chief R&D officer and chief commercial officer.
Viatris appointed Corinne Le Goff, PharmD, an alum of Amgen and Moderna, as chief commercial officer.
Stoke Therapeutics added Jason Hoitt as chief commercial officer.
Invivyd’s board of directors named Jeremy Gowler as interim CEO to succeed Dave Hering., effective immediately, while it searches for a permanent replacement.
Blue Cross of Idaho hired Reagan Greene as VP of brand, marketing and communications.
Chiesi USA named Richard Smith as VP, business unit leader for U.S. AIR.
Vittoria Biotherapeutics hired Keith Westby as chief operating officer.
Shelly West joined mRNA technologies company Etherna as its business development director, U.S.
Sensorium Therapeutics added Sam Rasty as chief business officer.
Branding and marketing agency Meyocks hired Marcie Garcia to lead its strategy function.
KBI Biopharma named Jean-Baptiste Agnus as chief business officer.
Clarified Precision Medicine appointed Rajni Natesan, MD, MBA as CEO.
Peregrine Market Access hired Mawais Farooqui as a data analyst and Lewis “Lewi” Clarke as an associate account executive.
Yosi Health added a number of executives to its leadership team.
Executive elevations:
Illumina named Jakob Wedel as chief strategy and corporate development officer, a position Goswami also held
Board appointments:
The CMT Research Foundation named Peter de Silva as board chair.
QuantHealth, an Israel-based AI-powered clinical trial simulation startup, announced members of its advisory board: former chief medical officer for AbbVie Rob Scott; former VP and global head of digital transformation and innovation execution at Novartis Christian Hein; and former Biogen CEO Michel Vounatsos.
Departures:
Illumina CFO Joydeep Goswami will exit and be replaced by Ankur Dhingra.
Ocular Therapeutix said CEO Antony Mattessich is leaving the company and will be replaced by executive chairman Pravin Dugel.
Miscellaneous:
The pharma, health and wellness judges were named for the 2024 Cannes Lions creative awards.
